Correlation Between Zenith Capital and Rigel Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zenith Capital and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zenith Capital and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zenith Capital Corp and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Zenith Capital and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zenith Capital with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zenith Capital and Rigel Pharmaceuticals.

Diversification Opportunities for Zenith Capital and Rigel Pharmaceuticals

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Zenith and Rigel is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Zenith Capital Corp and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Zenith Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zenith Capital Corp are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Zenith Capital i.e., Zenith Capital and Rigel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Zenith Capital and Rigel Pharmaceuticals

Assuming the 90 days horizon Zenith Capital Corp is expected to generate 17.59 times more return on investment than Rigel Pharmaceuticals. However, Zenith Capital is 17.59 times more volatile than Rigel Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Rigel Pharmaceuticals is currently generating about 0.05 per unit of risk. If you would invest  12.00  in Zenith Capital Corp on September 3, 2024 and sell it today you would lose (1.00) from holding Zenith Capital Corp or give up 8.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.79%
ValuesDaily Returns

Zenith Capital Corp  vs.  Rigel Pharmaceuticals

 Performance 
       Timeline  
Zenith Capital Corp 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Zenith Capital Corp are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent essential indicators, Zenith Capital reported solid returns over the last few months and may actually be approaching a breakup point.
Rigel Pharmaceuticals 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Rigel Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Rigel Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Zenith Capital and Rigel Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zenith Capital and Rigel Pharmaceuticals

The main advantage of trading using opposite Zenith Capital and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zenith Capital position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.
The idea behind Zenith Capital Corp and Rigel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity